Basal forebrain neurons in the dementia of Parkinson disease.
about
Executive dysfunction in Parkinson's disease and timing deficitsCholinergic imaging in dementia spectrum disordersFunctional neuroimaging in Parkinson's diseaseParkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's diseaseGalanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortexTherapeutic potential and health benefits of Sargassum speciesNeuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology.New MRI Biomarkers Advance the Characterization of Parkinson Disease.Genetically-directed, cell type-specific sparse labeling for the analysis of neuronal morphologyDifferential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.SPECT findings in Parkinson's disease associated with dementia.Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines.Cortical Lewy body dementia: clinical features and classification.The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's diseaseCerebral cortical and subcortical cholinergic deficits in parkinsonian syndromesEffects of a central cholinesterase inhibitor on reducing falls in Parkinson diseaseAn update on brain imaging in parkinsonian dementiaNeuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsyCell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).Cognitive slowing in Parkinson's disease resolves after practice.Acetylcholine excites neocortical pyramidal neurons via nicotinic receptorsPsychotic symptoms in Parkinson's disease: pathophysiology and management.Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.Neuroimaging and cognition in Parkinson's disease dementia.Parkinson's disease dementia: a neural networks perspective.Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brainBrain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice.Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.Biologic effects of nerve growth factor on lesioned basal forebrain neurons.Cognitive Impairment Associated with Parkinson's Disease: Role of Mitochondria.Neurotransmission in Parkinson's disease: beyond dopamine.The cholinergic system and Parkinson disease.Cholinergic dysfunction in Parkinson's disease.Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?Parkinson's disease dementia and potential therapeutic strategies.The Lewy body in Parkinson's disease and related neurodegenerative disorders.
P2860
Q21090466-14C37FBB-F5AB-48F0-9B93-F70BEA87DA78Q26764933-FDE56658-E4DE-486E-8243-4BF3F7BE876EQ27013767-DE0E21DC-0B82-4958-B7D5-1703566F5318Q27686837-EA10D8F9-1730-41C7-B764-E6A3E641B366Q28085513-8EE05C88-9454-47AF-AE74-36264B140930Q28235518-1094F515-0FAF-48DB-A1AC-A613CB4847CDQ28658760-0F3DEAA8-0498-4767-8E99-BADC12465F9CQ30756562-31EF566C-9416-487F-834A-2D8C1A6C0AA9Q30835312-7627074C-7B01-4D56-B042-AE624FA7FFAEQ33396661-A421A470-3EDA-43A8-B61A-14E1F42DD925Q33589160-F90D5944-1D31-42D2-AEFF-AB040BA918FEQ33591787-E894755D-304B-46FD-8AED-E4708080E4D6Q33619721-0AA59E89-4BB6-466B-BC2C-37E1F7234A85Q33621450-D131F6E9-000E-4E28-82CF-DD56108D64F5Q33629696-D0E9B9F7-C2B3-42F8-BFDB-1C3C97738336Q33631292-CD807D21-1AAD-4B75-9191-7019D688D46AQ33853330-526BE281-1AA7-45E8-B519-90A2A5E158F9Q34135495-3030D372-C1B7-4678-8A5B-693CDFD1CC1CQ34327937-F258DFCF-8305-40ED-8962-5A6835CD4B57Q34340994-55E65739-E8C5-4FEA-8D7E-779AD69665C8Q35024248-9E83F017-F19D-4F08-AD39-0571FE40A4A4Q35108246-C9037440-0BA5-4628-A949-85D3C58D6A72Q35469822-E1EEC65F-933C-495E-9335-E712FFD7366FQ35560215-56D907D0-C146-4B6A-901A-D375CC16E075Q35779329-CEC91F42-4E45-4601-B28F-C712ECC7418EQ35863422-75DC25ED-5669-4E26-924E-7EA8B5A80546Q35891782-7F6F0B75-1976-44AA-9393-6D8BBF4D7E48Q36186763-FA0D99C7-B679-4CC3-88D2-310D69F11892Q36273938-6FC4D42F-14FB-4E9A-AE72-A97F46C18235Q36318598-F1558AB5-C964-4D1D-80C7-35E2B0D61D4EQ36486037-AD96F3C2-4344-418A-99ED-4B07EF3A921AQ36834550-3AF7E6C4-6D82-48A1-9B59-24CEBF20C6D3Q36927536-38B0AFCA-BE6A-471F-B429-2980417B0EA3Q37168743-61C8299E-6034-47AC-B296-9AB10BC13646Q37668684-C8786040-9AF0-4F02-81CE-C83DE36EE2F9Q37671065-3D6DDE23-63BA-4FF3-92F9-CA643E9A3B9BQ37709932-EFD9B8D7-B79E-43F3-8168-EAC19C879BD7Q37812906-C2F3D89D-AE96-4F3B-A567-92DBB77C1B53Q37825631-8519F2D7-7F7A-4135-A5FA-7712AEEEBCFAQ38012653-4C19DDF9-66CD-47A9-94F6-647A64DD04B7
P2860
Basal forebrain neurons in the dementia of Parkinson disease.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Basal forebrain neurons in the dementia of Parkinson disease.
@en
Basal forebrain neurons in the dementia of Parkinson disease.
@nl
type
label
Basal forebrain neurons in the dementia of Parkinson disease.
@en
Basal forebrain neurons in the dementia of Parkinson disease.
@nl
prefLabel
Basal forebrain neurons in the dementia of Parkinson disease.
@en
Basal forebrain neurons in the dementia of Parkinson disease.
@nl
P2093
P356
P1433
P1476
Basal forebrain neurons in the dementia of Parkinson disease.
@en
P2093
Hedreen JC
White CL 3rd
Whitehouse PJ
P304
P356
10.1002/ANA.410130304
P577
1983-03-01T00:00:00Z